Animation - Understanding NSCLC Treatment Options When You Have a KRAS Mutation
Slide Show - Understanding NSCLC Treatment Options When You Have a KRAS Mutation
1.
What is a gene mutation and how does it relate to lung cancer?
2.
How do doctors test for genetic mutations in lung cancer and why is it important?
3.
What is comprehensive biomarker testing for lung cancer? What do I need to know?
4.
What is a KRAS mutation in non-small cell lung cancer (NSCLC)?
5.
How do doctors treat lung cancer with KRAS mutations?
6.
How did you find out you had KRAS-positive lung cancer?
7.
What was the comprehensive biomarker testing experience like?
8.
What has your treatment experience been for your KRAS-positive lung cancer?
9.
What advice do you have for newly diagnosed lung cancer patients about biomarker testing?
10.
How did you find out you had KRAS-positive lung cancer?
11.
How has your KRAS mutation affected the treatment options available to you?
Animation - Understanding NSCLC Treatment Options When You Have a KRAS Mutation
This animation provides an overview of KRAS mutations in non-small cell lung cancer (NSCLC) and different treatment options. The first treatment for NSCLC with a KRAS mutation may include surgery, radiation, and chemotherapy. The exact treatment depends on the stage of cancer, your general health, and other factors. Watch to learn about biomarker testing, targeted therapy that targets the KRAS G12C mutation, side effects of KRAS inhibitors, clinical trials, and more.
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.
Section: NSCLC Treatment When You Have a KRAS Mutation
Expert Videos
Patient Videos
Animation - Understanding NSCLC Treatment Options When You Have a KRAS Mutation
Slide Show - Understanding NSCLC Treatment Options When You Have a KRAS Mutation
1.
What is a gene mutation and how does it relate to lung cancer?
2.
How do doctors test for genetic mutations in lung cancer and why is it important?
3.
What is comprehensive biomarker testing for lung cancer? What do I need to know?
4.
What is a KRAS mutation in non-small cell lung cancer (NSCLC)?
5.
How do doctors treat lung cancer with KRAS mutations?
6.
How did you find out you had KRAS-positive lung cancer?
7.
What was the comprehensive biomarker testing experience like?
8.
What has your treatment experience been for your KRAS-positive lung cancer?
9.
What advice do you have for newly diagnosed lung cancer patients about biomarker testing?
10.
How did you find out you had KRAS-positive lung cancer?
11.
How has your KRAS mutation affected the treatment options available to you?
